SPDR S&P Pharmaceuticals ETF (XPH) Short Interest Down 38.6% in December

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 624,362 shares, a decline of 38.6% from the November 30th total of 1,017,493 shares. Based on an average trading volume of 175,689 shares, the days-to-cover ratio is presently 3.6 days.

Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) opened at $44.44 on Friday. SPDR S&P Pharmaceuticals ETF has a 12 month low of $37.16 and a 12 month high of $44.73. The company has a market cap of $401.04 and a price-to-earnings ratio of 2.81.

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 26th. Investors of record on Monday, December 18th were given a dividend of $0.108 per share. The ex-dividend date was Friday, December 15th. This represents a $0.43 dividend on an annualized basis and a dividend yield of 0.97%. SPDR S&P Pharmaceuticals ETF’s payout ratio is presently 1.84%.

TRADEMARK VIOLATION WARNING: “SPDR S&P Pharmaceuticals ETF (XPH) Short Interest Down 38.6% in December” was reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.americanbankingnews.com/2018/01/05/spdr-sp-pharmaceuticals-etf-xph-short-interest-down-38-6-in-december.html.

Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply